TAPI offers customized CDMO Solutions for API development and manufacturing services.
01 1TAPI Technology & API Services
02 1Amino Chemicals
03 1Apotex Pharmachem
04 1Aurobindo Pharma Limited
05 1Centaur Pharmaceuticals
06 1Chemical Bull
07 1Chromo Laboratories
08 1Cipla
09 1Enomark
10 1Gador SA
11 1Guangzhou Tosun Pharmaceutical
12 1Jiangsu Nhwa Pharmaceutical
13 1NAC Chemical
14 1Orchid Pharma
15 1Precise Group
16 1Teva Pharmaceutical Industries
17 1Zydus Lifesciences
01 1Argentina
02 1Canada
03 2China
04 10India
05 2Israel
06 1Malta
01 4Active
02 5Inactive
03 8Blank
01 17Blank
01 17Blank
01 1WC-0017
02 1WC-0107
03 1WC-0317
04 14Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17565
Submission : 2004-07-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20877
Submission : 2007-09-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19398
Submission : 2006-04-26
Status : Active
Type : II
Date of Issue : 2022-06-06
Valid Till : 2025-06-10
Written Confirmation Number : WC-0017
Address of the Firm :
NDC Package Code : 65862-197
Start Marketing Date : 2024-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-02
Pay. Date : 2013-09-25
DMF Number : 27568
Submission : 2013-09-25
Status : Active
Type : II
Date of Issue : 2022-06-08
Valid Till : 2025-06-25
Written Confirmation Number : WC-0107
Address of the Firm :
NDC Package Code : 64330-054
Start Marketing Date : 2018-01-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22572
Submission : 2009-02-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21482
Submission : 2008-04-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18022
Submission : 2005-01-26
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19015
Submission : 2005-12-13
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16785
Submission : 2003-08-20
Status : Inactive
Type : II
Date of Issue : 2022-02-02
Valid Till : 2024-06-07
Written Confirmation Number : WC-0317
Address of the Firm :
NDC Package Code : 52562-017
Start Marketing Date : 2021-06-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Zaleplon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zaleplon, including repackagers and relabelers. The FDA regulates Zaleplon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zaleplon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zaleplon manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zaleplon supplier is an individual or a company that provides Zaleplon active pharmaceutical ingredient (API) or Zaleplon finished formulations upon request. The Zaleplon suppliers may include Zaleplon API manufacturers, exporters, distributors and traders.
click here to find a list of Zaleplon suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 17 companies offering Zaleplon
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?